Clinical Trials in Avondale, Arizona

Find clinical trials in Avondale, Arizona. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Avondale

Showing 8 trials on this page

Page 1 of 1

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT ID: NCT04929210

This clinical trial is studying a medication called guselkumab to see how well it works for people with active psoriatic arthritis (PsA) that affects the spine and pelvis. The goal is to find out i...

Recruiting

Phase: PHASE4 Conditions: Arthritis, Psoriatic

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT ID: NCT06617325

This clinical trial is studying a new treatment called dapirolizumab pegol (DZP) for people with moderately to severely active systemic lupus erythematosus (SLE), a chronic autoimmune disease that ...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

NCT ID: NCT06641076

This clinical trial is studying a medication called sonelokimab to see how well it works and how safe it is for adults with active psoriatic arthritis, a type of arthritis that can cause joint pain...

Recruiting

Phase: PHASE3 Conditions: Arthritis, Psoriatic

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

NCT ID: NCT06641089

This clinical trial is studying a new treatment called sonelokimab for adults with active psoriatic arthritis (PsA) who haven’t had enough relief from their previous treatments using anti-TNFα medi...

Recruiting

Phase: PHASE3 Conditions: Arthritis, Psoriatic

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

NCT ID: NCT06331312

This clinical trial is looking at the long-term safety and tolerability of a medication called secukinumab for patients with polymyalgia rheumatica (PMR), a condition that causes muscle pain and st...

Recruiting

Phase: PHASE3 Conditions: Polymyalgia Rheumatica

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

NCT ID: NCT06864026

The TOGETHER AMPLIFY-PsA clinical trial is studying how effective the medication tirzepatide is when added to ixekizumab treatment for people with active psoriatic arthritis (PsA) who are also over...

Recruiting

Phase: PHASE4 Conditions: Psoriatic Arthritis, Overweight or Obesity

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

NCT ID: NCT06613360

This clinical trial is studying a new treatment called CLN-978, which is designed to help people with moderate to severe Systemic Lupus Erythematosus (SLE). SLE is an autoimmune disease where the b...

Recruiting

Phase: PHASE1 Conditions: SLE, SLE (Systemic Lupus)

A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

NCT ID: NCT06859294

This clinical trial is studying a new medication called LY3541860 to see how it helps adults with moderately to severely active rheumatoid arthritis (RA) who have not responded well to at least one...

Recruiting

Phase: PHASE2 Conditions: Rheumatoid Arthritis

Search All Trials Browse All Locations